NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Ischemic Stroke
    Ischemic Stroke
    medium
    stethoscope Medicine

    A 58-year-old man from Delhi presents to the emergency department with acute onset of right-sided weakness and slurred speech that began 2 hours ago while he was at work. His wife reports he has hypertension (on amlodipine) and type 2 diabetes (on metformin). On examination, blood pressure is 168/98 mmHg, heart rate 92/min regular, and he has right-sided hemiparesis with facial droop. Non-contrast CT head shows no hyperdensity. Blood glucose is 156 mg/dL. What is the most appropriate next step in management?

    A. Initiate heparin infusion and refer to neurosurgery
    B. Administer intravenous alteplase 0.9 mg/kg within the next 30 minutes
    C. Perform urgent MRI brain with diffusion-weighted imaging
    D. Start aspirin 300 mg and observe for 24 hours before imaging

    Explanation

    ## Clinical Scenario Analysis This patient presents with acute ischemic stroke symptoms within the 4.5-hour thrombolytic window (onset at 2 hours, now presenting immediately). Non-contrast CT excludes hemorrhage, which is the critical safety prerequisite for thrombolysis. ## Thrombolytic Eligibility **Key Point:** Intravenous alteplase (rt-PA) is indicated for acute ischemic stroke within 4.5 hours of symptom onset in eligible patients, with the strongest evidence for benefit within 3 hours. **High-Yield:** The patient meets inclusion criteria: - Time window: 2 hours (well within 4.5 hours) - CT head negative for hemorrhage - No contraindications mentioned (no recent surgery, no anticoagulation, no severe hyperglycemia) - NIHSS score implied to be significant (facial droop + hemiparesis) ## Dosing and Administration Alteplase dosing for acute stroke: - **Total dose:** 0.9 mg/kg (maximum 90 mg) - **Bolus:** 10% of total dose over 1 minute - **Infusion:** Remaining 90% over 60 minutes **Clinical Pearl:** Every minute of delay in reperfusion results in loss of ~1.9 million neurons. "Time is brain" — thrombolysis should not be delayed for additional imaging once CT excludes hemorrhage and clinical presentation is consistent with stroke. ## Why This Approach ```mermaid flowchart TD A[Acute stroke symptoms < 4.5 hrs]:::outcome --> B{CT head negative for ICH?}:::decision B -->|Yes| C{Eligible for thrombolysis?}:::decision C -->|Yes| D[IV alteplase 0.9 mg/kg]:::action C -->|No| E[Aspirin + supportive care]:::action B -->|No| F[Hemorrhagic stroke protocol]:::urgent D --> G[Monitor for reperfusion/complications]:::action ``` **Mnemonic: THROMBOLYSIS WINDOW** — Time < 4.5 hrs, Hemorrhage excluded, Reasonable deficits, Onset documented, Monitoring available, Blood glucose acceptable, Onset witnessed, Lesion on imaging (optional), Young/old no absolute bar, Signs consistent, Imaging CT done, Seizure/sepsis ruled out. ![Ischemic Stroke diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/34508.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions